These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7827113)

  • 1. Characterization of a new class of inhibitors of the recombinant human liver UDP-glucuronosyltransferase, UGT1*6.
    Battaglia E; Elass A; Drake RR; Paul P; Treat S; Magdalou J; Fournel-Gigleux S; Siest G; Vergoten G; Lester R
    Biochim Biophys Acta; 1995 Jan; 1243(1):9-14. PubMed ID: 7827113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoaffinity labeling for evaluation of uridinyl analogs as specific inhibitors of rat liver microsomal UDP-glucuronosyltransferases.
    Radominska A; Paul P; Treat S; Towbin H; Pratt C; Little J; Magdalou J; Lester R; Drake R
    Biochim Biophys Acta; 1994 Apr; 1205(2):336-45. PubMed ID: 8155717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical modification of human UDP-glucuronosyltransferase UGT1*6 by diethyl pyrocarbonate: possible involvement of a histidine residue in the catalytic process.
    Battaglia E; Pritchard M; Ouzzine M; Fournel-Gigleux S; Radominska A; Siest G; Magdalou J
    Arch Biochem Biophys; 1994 Mar; 309(2):266-72. PubMed ID: 8135537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective and potent inhibition of different hepatic UDP-glucuronosyltransferase activities by omega,omega,omega-triphenylalcohols and UDP derivatives.
    Said M; Noort D; Magdalou J; Ziegler JC; van der Marel GA; van Boom JH; Mulder GJ; Siest G
    Biochem Biophys Res Commun; 1992 Aug; 187(1):140-5. PubMed ID: 1520294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemical modification of human liver UDP-glucuronosyltransferase UGT1*6 reveals the involvement of a carboxyl group in catalysis.
    Battaglia E; Senay C; Fournel-Gigleux S; Herber R; Siest G; Magdalou J
    FEBS Lett; 1994 Jun; 346(2-3):146-50. PubMed ID: 8013623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monometoxytrityl derivatives of uridine as inhibitors of a human recombinant UDP-glucuronosyltransferase: UGT1*6.
    Cano V; Lorentz C; Magdalou J; Loppinet V; Siest G; Ziegler JC
    Life Sci; 1997; 61(1):PL1-8. PubMed ID: 9200672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of UDP-glucuronosyltransferase by 5'-O-amino acid and oligopeptide derivatives of uridine: structure-activity relationships.
    Naydenova ZG; Grancharov KC; Alargov DK; Golovinsky EV; Stanoeva IM; Shalamanova LD; Pajeva IK
    Z Naturforsch C J Biosci; 1998; 53(3-4):173-81. PubMed ID: 9687161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of UDP-glucuronosyltransferase activity by possible transition-state analogues in rat-liver microsomes.
    Noort D; Coughtrie MW; Burchell B; van der Marel GA; van Boom JH; van der Gen A; Mulder GJ
    Eur J Biochem; 1990 Mar; 188(2):309-12. PubMed ID: 2108023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant human UDP-glucuronosyltransferase 1A9--potent inhibition by niflumic acid.
    Mano Y; Usui T; Kamimura H
    Biopharm Drug Dispos; 2006 Jan; 27(1):1-6. PubMed ID: 16278927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acitretin exhibits inhibitory effects towards UDP-glucuronosyltransferase (UGT)1A9-mediated 4-methylumbelliferone (4-MU) and propofol glucuronidation reaction.
    Yu ML; Yang Y; Wang CM; Zhang MM; Bai MC; Guo YL
    Pharmazie; 2013 Jun; 68(6):449-52. PubMed ID: 23875253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition potential of glimepiride (gli) towards important UDP-glucuronosyltransferase (UGT) isoforms in human liver.
    Fu JF; Ren QY; Zhang NY; Gao B; Tu YY; Fu GQ; Li DH; Zhang YS
    Pharmazie; 2012 Aug; 67(8):715-7. PubMed ID: 22957438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoaffinity labeling studies of the human recombinant UDP-glucuronosyltransferase, UGT1*6, with 5-azido-UDP-glucuronic acid.
    Battaglia E; Nowell S; Drake RR; Magdalou J; Fournel-Gigleux S; Senay C; Radominska A
    Drug Metab Dispos; 1997 Apr; 25(4):406-11. PubMed ID: 9107538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic and inhibitor studies of 4-methylumbelliferone and 1-naphthol glucuronidation in human liver microsomes.
    Miners JO; Lillywhite KJ; Matthews AP; Jones ME; Birkett DJ
    Biochem Pharmacol; 1988 Feb; 37(4):665-71. PubMed ID: 3124857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evidence for the involvement of at least two forms of human liver UDP-glucuronosyltransferase in morphine 3-glucuronidation.
    Miners JO; Lillywhite KJ; Birkett DJ
    Biochem Pharmacol; 1988 Jul; 37(14):2839-45. PubMed ID: 3134892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of a new class of inhibitors of membrane-associated UDP-glycosyltransferases.
    Paul P; Lutz TM; Osborn C; Kyosseva S; Elbein AD; Towbin H; Radominska A; Drake RR
    J Biol Chem; 1993 Jun; 268(17):12933-8. PubMed ID: 8509426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus strongly inhibits multiple human UDP-glucuronosyltransferase (UGT) isoforms.
    Liu XY; Fang ZZ; Dong PP; Shi XH; Teng YJ; Sun XY
    Pharmazie; 2012 Sep; 67(9):804-8. PubMed ID: 23016456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine 52 and histidine 54 located in a conserved amino-terminal hydrophobic region (LX2-R52-G-H54-X3-V-L) are important amino acids for the functional and structural integrity of the human liver UDP-glucuronosyltransferase UGT1*6.
    Senay C; Ouzzine M; Battaglia E; Pless D; Cano V; Burchell B; Radominska A; Magdalou J; Fournel-Gigleux S
    Mol Pharmacol; 1997 Mar; 51(3):406-13. PubMed ID: 9058595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the drug inhibitor specificity of the human liver 4-methylumbelliferone UDP-glucuronosyltransferase activity.
    Miners JO; Lillywhite KJ
    Biochem Pharmacol; 1991 Mar; 41(5):838-41. PubMed ID: 1900159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by udp-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites.
    Uchaipichat V; Galetin A; Houston JB; Mackenzie PI; Williams JA; Miners JO
    Mol Pharmacol; 2008 Oct; 74(4):1152-62. PubMed ID: 18647858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.